Practical consequences after MRSA identification in chronic wounds;Praktische konsequenzen durch den nachweis von MRSA in chronischen wunden

Hautarzt

Volumn 58, Issue 11, 2007, Pages 952-958

  Dissemond, J ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Chronic wound; MRSA; MSSA; ORSA; VRSA

Indexed keywords

ANTIBIOTIC AGENT; BETA DEFENSIN; EXTENDED SPECTRUM BETA LACTAMASE; FUSIDATE SODIUM; GLYCOPEPTIDE ANTIBIOTIC; LINEZOLID; NANOCRYSTAL; PSEUDOMONIC ACID; RIFAMPICIN; STREPTOGRAMIN DERIVATIVE; STREPTOGRAMINE QUINOPRISTINE; TEICOPLANIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ALTERNATIVE MEDICINE; ANTIBIOTIC RESISTANCE; BACTERIOPHAGE; BACTERIUM CONTAMINATION; BACTERIUM IDENTIFICATION; CHRONIC WOUND; COST BENEFIT ANALYSIS; DRUG EFFICACY; ENZYME MECHANISM; ERADICATION THERAPY; HIGH RISK PATIENT; HOSPITAL HYGIENE; HOSPITAL INFECTION; HUMAN; HYDROTHERAPY; HYPERTHERMIA; ISOLATION PROCEDURE; METHICILLIN RESISTANT STAPHYLOCOCCUSAAUREUS; MODULATION; PATIENT CARE; PH; REVIEW; STAPHYLOCOCCUS AUREUS; SYSTEMIC THERAPY; THROAT CULTURE; WOUND CARE; WOUND HEALING;

ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; HUMANS; HYDROTHERAPY; HYPERTHERMIA, INDUCED; META-ANALYSIS AS TOPIC; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; TIME FACTORS; ULTRASONIC THERAPY; WOUND HEALING; WOUND INFECTION;

EID: 36048988464     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-007-1403-0     Document Type: Review

References (46)

1. Anonymous (1999) Empfehlung zur Prävention von Methicilin- resistenten Staphylococcus aureus Stämmen (MRSA) in Krankenhäusern und anderen medizinischen Einrichtungen. Bundesgesundheitsblatt 12: 954-958
2. Bonn D (2000) Maggot therapy: an alternative for wound infection. Lancet 356: 1174
3. CDC (2002) Staphylococcus aureus resistant to vancomycin-United States 2002. MMWR Morb Mortal Wkly Rep 51: 565-567
4. Colsky AS, Kirsner RS, Kerdel FA (1998) Analysis of antibiotic susceptibilities of wound flora in hospitalised dermatology patients: the crisis of antibiotic resistance has come to the surface. Arch Dermatol 134: 1006-1009
5. Cosgrove SE, Sakoulas G, Perencevich EN et al. (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36: 53-59
6. d'Audiffret A, Roethle S, Tretinyak A, Santilli S (2002) Use of a non-contact radiant heat bandage on ischemic dermal infections in an ovine model. Med Sci Monit 8:289-292
7. Dissemond J, Geisheimer M, Goos M (2004) Eradikation eines ORSA bei einem Patienten mit Ulcus cruris durch Lavasept-Gel. ZfW 1: 29-32
8. Dissemond J, Koppermann M, Esser S et al. (2002) Therapie eines Methicillin-resistenten Staphylokokkus aureus (MRSA) im Rahmen der Behandlung eines chronischen Ulcus mittels Biochirurgie. Hautarzt 53: 608-612
9. Dissemond J, Körber A, Lehnen M, Grabbe S (2005) Methicillin resistenter Staphylococcus aureus (MRSA) in chronischen Wunden: Therapeutische Optionen und Perspektiven. J Dtsch Dermatol Ges 3: 256-262
10. Dissemond J, Schmid EN, Esser S et al. (2004) Untersuchungen zur bakteriellen Kolonisation chronischer Wunden in einer universitären dermatologischen Wundambulanz unter besonderer Berücksichtigung von ORSA. Hautarzt 55: 280-288
11. Ellis SL, Finn P, Noone M, Leaper DJ (2003) Eradication of methicillin-resistant Staphylococcus aureus from pressure sores using warming therapy. Surg Infect 4: 53-55
12. Filius PM, Gyssens IC (2002) Impact of increasing antimicrobial resistance on wound management. Am J Clin Dermatol 3: 1-7
13. Flemming K, Cullum N (2000) Therapeutic ultrasound for venous leg ulcers. Cochrane Database Syst Rev 4: 1180
14. Fridkin SK, Hageman JC, Morrison M et al. (2005) Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352: 1436-1444
15. Gillet Y, Issartel B, Vanhems P et al. (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2(359): 753-759
16. Grohs P, Kitzis MD, Gutmann L (2003) In vitro bactercidal activities of linezolid in combination with vancomycin, gentamycin, ciprofloxacin, fusidic acid, and rifampin against staphylococcus aureus. Antimicrob Agents Chemother 47: 418-420
17. Harbarth S, Dharan S, Liassine N et al. (1999) Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 43: 1412-1416
18. Hiramatsu K (2001) Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis 1: 147-155
19. Hon KL, Lam MC, Leung TF et al. (2005) Clinical features associated with nasal Staphylococcus aureus colonisation in Chinese children with moderate-to-severe atopic dermatitis. Ann Acad Med Singapore 34: 602-605
20. Jappe U, Petzoldt D, Wendt C (2004) Methicillin-resistant Staphylococcus aureus colonization in inflammatory versus non-inflammatory skin diseases: who should be screened? Acta Derm Venereol 84: 181-186
21. Jasir A, Kasprzykowski F, Lindstrom V et al. (2004) New antimicrobial peptide active against Gram-positive pathogens. Indian J Med Res 119: 74-76
22. Kac G, Buu-Hoi A, Herisson E et al. (2000) Methicillin-resistent staphylococcus aureus. Nosocomial acquisition and carrier state in a wound care center. Arch Dermatol 136: 735-739
23. Knighton DR, Fiegel VD, Halverson T et al. (1990) Oxygen as an antibiotic. The effect of inspired oxygen on bacterial clearance. Arch Sur 125: 97-100
24. Krasagakis K, Samonis G, Maniatakis P et al. (2006) Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance. Dermatology 212: 31-35
25. Leszczynski P, Weber-Dabrowska B, Kohutnicka M et al. (2006) Successful eradication of methicillin-resistant Staphylococcus aureus (MRSA) intestinal carrier status in a healthcare worker - a case report. Folia Microbiol 51: 236-238
26. Linde HJ, Lehn N (2002) Methicillin-resistenter Staphylococcus aureus (MRSA). Hautarzt 53: 690-701
27. Mertz PM, Oliveira-Gandia MF, Davis SC (1999) The evaluation of a cadoxomer iodine wound dressing on methicillin resistant staphylococcus aureus (MRSA) in acute wounds. Dermatol Surg 25: 89-93
28. Natarajan S, Williamson D, Grey J et al. (2001) Healing of an MRSA-colonized, hydroxyurea-induced leg ulcer with honey. J Dermatolog Treat 12: 33-36
29. O'Meara S, Cullum N, Majid M, Sheldon T (2000) Systemic review of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration. Health Technol Assessment 4: 1-237
30. Ohwada A, Sekiya M, Hanaki H et al. (1999) DNA vaccination by mecA sequence evokes an antibacterial immune response against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 44: 767-774
31. Okano M, Nagouchi S, Tabata K, Matsumoto Y (2000) Topical gentian violet for cutaneous infection and nasal carriage with MRSA. Int J Dermatol 39: 942-944
32. Paladino JA (2002) Linezolid: an oxazolidinone antimicrobial agent. Am J Health Syst Pharm 59: 2413-2425
33. Patil R, Baveja S, Nataraj G, Khopkar U (2006) Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in community-acquired primary pyoderma. Indian J Dermatol Venereol Leprol 72: 126-128
34. Robbins JB, Schneerson R, Horwith G et al. (2004) Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines. Am Heart J 147: 593-598
35. Roghmann MC, Siddiqui A, Plasance K, Standiford H (2001) MRSA colonization and the risk of MRSA bacteriemia in hospitalized patients with chronic ulcers. J Hosp Infect 47: 98-103
36. Spangler D, Rothenburger S, Nguyen K et al. (2003) In vitro antimicrobial activity of oxidized regenerated cellulose against antibiotic-resistant microorganisms. Surg Infect 4: 255-262
37. Stone GW, Zhang Q, Castillo R et al. (2004) Mechanism of action of NB2001 and NB2030, novel antibacterial agents activated by beta-lactamases. Antimicrob Agents Chemother 48: 477-483
38. Stone LL, Dalton HP, Haynes BW (1980) Bacterial debridement of the burn eschar: the in vivo activity of selected organisms. J Surg Res 29: 83-92
39. Thai TP, Houghton PE, Campell KE, Wodbury MG (2002) Ultraviolet light C in the treatment of chronic wounds with MRSA: a case study. Ostomy Wound Management 48: 52-60
40. Valencia IC, Kirsner RS, Kerdel FA (2004) Microbiologic evaluation of skin wounds: alarming trend toward antibiotic resistance in an inpatient dermatology service during a 10-year period. J Am Acad Dermatol 50: 845-849
41. von Eiff C, Peters G (1999) Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci. J Antimicrobial Chemother 43: 569-573
42. Voss A, Milatovic D, Wallrauch-Schwarz C et al. (1994) Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 13: 50-55
43. Whitby M, McLaws ML, Berry G (2001) Risk of death from methicillin-resistant staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 175: 264-267
44. Witte W, Wiese-Posselt M, Jappe U (2005) Community MRSA - Eine neue Herausforderung für die Dermatologie. Hautarzt 56: 731-738
45. Wright JB, Lam K, Burrell RE (1998) Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment. Am J Infect Control 26: 572-577
46. Zeina B, Greenman J, Purcell WM, Das B (2001) Killing of cutaneous microbial species by photodynamic therapy. Br J Dermatol 144: 274-278